Previous 10 | Next 10 |
IVERIC bio (NASDAQ:ISEE) +65% Apellis' mixed eye-drug data turns out to be 'positive' for Iveric Bio Vince Holding (NYSE:VNCE) +22% on Q2 earnings. Affirm Holdings (NASDAQ:AFRM) +21% on Q4 earnings. Endo International (NASDAQ:ENDP) +18% settles New York state opi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re back at it again with one last day of trading this week and we’re kicking it off with a dive into Friday’s biggest pre-market stock movers. Source: Shutterstock The...
Shares of IVERIC bio Inc. (NASDAQ:ISEE) traded today at $10.80, eclipsing its 52-week high. So far today approximately 1.7 million shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. IVERIC bio Inc is a biopharmaceutical company focused on the disco...
Shares of IVERIC bio Inc. (NASDAQ:ISEE) traded today at $10.60, eclipsing its 52-week high. Approximately 1.7 million shares have changed hands today, as compared to an average 30-day volume of 1.4 million shares. In the past 52 weeks, IVERIC bio Inc. share prices are bracketed by a low ...
Gainers: LMNL +15.0%. SONO +10.6%. HUT +8.2%. EBON +4.5%. CAN +4.0%. Losers: JRJC -13.8%. WDC -6.1%. SDGR -5.6%. OGI -4.5%. ISEE -2.7%. For further details see: LMNL, SONO, JRJC and WDC among after hours movers
IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present an overview of the Company at the H.C. Wainwright Ophthalmology Virtual Conference on Tuesday, August 17, 2021. This on-demand presentation will be available at 7:00 a.m. Eastern Time...
The following slide deck was published by IVERIC bio, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: IVERIC bio, Inc. 2021 Q2 - Results - Earnings Call Presentation
IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will participate in the panel discussion, “Only Have Eyes For You - Ophthalmic Gene Therapy,” at the 2021 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11 at...
IVERIC bio, Inc. (ISEE) Q2 2021 Results Earnings Conference Call August 4, 2021, 08:00 AM ET Company Participants Kathy Galante - Senior Vice President, Investor Relations Glenn Sblendorio - Chief Executive Officer Keith Westby - Chief Operating Officer Pravin Dugel - President David Carroll ...
IVERIC bio (NASDAQ:ISEE): Q2 GAAP EPS of -$0.32 misses by $0.06. As of June 30, 2021, the Company had $159.9 million in cash and cash equivalents. Press Release For further details see: IVERIC bio EPS misses by $0.06
News, Short Squeeze, Breakout and More Instantly...
Astellas Completes Acquisition of Iveric Bio PR Newswire TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") today announced that it has successfully completed the acquisit...
Shares of IVERIC bio, Inc. (NASDAQ: ISEE) traded at a new 52-week high today and are currently trading at $39.73. So far today, approximately 1.78M shares have been exchanged, as compared to an average 30-day volume of 5.04M shares. IVERIC bio, Inc., a biopharmaceutical company, discovers and...
IVERIC bio, Inc. (NASDAQ: ISEE) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 1.93% on the day to $38.77. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal disease...